DNA

Q: What is the price of Ginkgo Bioworks Holdings (DNA) today?

The price of Ginkgo Bioworks Holdings (DNA) today is US$ 13,52, with a variation of 84.45% compared to the last year. The price of Ginkgo Bioworks Holdings (DNA) started the year trading around US$ 0,00 and today it is at US$ 13,52. Follow the real-time price chart, the historical price of Ginkgo Bioworks Holdings (DNA), and stock data from Ibovespa and international markets.

Q: When does Ginkgo Bioworks Holdings (DNA) pay dividends?

Ginkgo Bioworks Holdings (DNA) did not distribute dividends in the last year.

Q: Ginkgo Bioworks Holdings (DNA) is it worth it?

Currently, Ginkgo Bioworks Holdings (DNA) is priced at US$ 13,52, with a P/E of -2,78%, representing a deviation of -7,67% from its historical average P/E. In the last year, the stock showed a variation of 84.45% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 84,45%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Ginkgo Bioworks Holdings (DNA)?

Investing in stocks of Ginkgo Bioworks Holdings (DNA) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Ginkgo Bioworks Holdings (DNA) yield today?

The yield of Ginkgo Bioworks Holdings (DNA) was 31,39% in the last month, 84,45% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Ginkgo Bioworks Holdings (DNA) today, the total investment would be US$ 1.352,00, based on the current price of US$ 13,52.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 2.493,76In 5 years: US$ 1.352,00In 10 years: 1.352,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Ginkgo Bioworks Holdings

Price

US$ 13,52

variation (12m)

84,45%

p/l

-2,78

p/vp

1,45

DIVIDEND YIELD

0,00%

price DNA

BVMF

DNA

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of DNA

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

31,39%

3 months

36,02%

1 year

84,45%

2 years

-79,14%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

31,39%

3 months

35,52%

1 year

76,36%

2 years

-80,96%

5 years

0,00%

10 years

0,00%

Indicators DNA

check out the fundamentals of Ginkgo Bioworks Holdings shares

P/E

-2,78

Sector: 8,92 Industry: 8,92

P/SALES RATIO (PSR)

4,64

Sector: 2,58 Industry: 2,58

P/BV

1,45

Sector: 2,40 Industry: 2,40

DIVIDEND YIELD (DY)

0,00%

Sector: 0,88% Industry: 0,88%

ROA

-25,92%

Sector: 1,27% Industry: 1,27%

ROE

-52,06%

Sector: 5,69% Industry: 5,69%

ROIC

-32,87%

Sector: -44,66% Industry: -44,66%

NET MARGIN

-100,00%

Sector: 4,09% Industry: 4,09%

GROSS MARGIN

73,19%

Sector: 33,14% Industry: 33,14%

OPERATING MARGIN

-100,00%

Sector: 5,50% Industry: 5,50%

P/EBITDA

-2,92

Sector: 2,84 Industry: 2,84

P/EBIT

-2,42

Sector: 0,20 Industry: 0,20

P/ASSET

0,72

Sector: 1,19 Industry: 1,19

BVPS

11,14

Sector: 9,89 Industry: 9,89

EPS

-5,80

Sector: 0,81 Industry: 0,81

EQUITY / ASSETS

0,50

Sector: 0,43 Industry: 0,43

CAGR REVENUES 5 YEARS

26,68%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

20,20%

Sector: - Industry: -

DNA indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
META	24,13	9,17	38,02%	0,29%	US$ 1,79 T	39,93%
INTR	19,08	2,35	12,32%	0,89%	US$ 3,98 B	15,52%
PBR	6,31	1,09	17,20%	15,86%	US$ 79,91 B	15,08%
PLTR	536,24	67,93	12,67%	0,00%	US$ 409,31 B	22,19%
VALE	9,45	1,15	12,18%	6,52%	US$ 46,62 B	13,76%
SHEL	16,86	1,19	7,05%	3,87%	US$ 217,73 B	4,85%
MAIN	10,47	1,94	18,56%	6,69%	US$ 5,60 B	86,83%
BDORY	10,11	0,70	6,89%	8,07%	US$ 23,41 B	9,29%
STLA	42,47	0,36	0,86%	6,66%	US$ 30,93 B	0,22%
ENB	20,22	2,18	10,80%	5,37%	US$ 109,15 B	11,73%
NSRGY	9,71	6,70	69,01%	3,65%	US$ 239,31 B	11,63%
BBSEY	7,61	6,38	83,87%	12,15%	US$ 12,07 B	100,00%
UNH	17,52	3,12	17,80%	2,39%	US$ 326,70 B	4,30%
SAN	10,69	1,28	11,94%	2,20%	US$ 160,47 B	22,41%
TTE	10,31	1,14	11,08%	5,86%	US$ 135,96 B	7,15%
TD	6,87	1,52	22,16%	3,67%	US$ 139,47 B	47,06%
ITUB	10,15	1,96	19,34%	6,99%	US$ 77,32 B	28,45%
BNS	15,00	1,30	8,67%	4,72%	US$ 81,17 B	20,79%

comparison of DNA with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History DNA

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings

Average user rating I10

4.0 (2 people)

Estados Unidos

- year

Foundation:

Year of debut on the stock exchange - - year

-

Employees

The Company Ginkgo Bioworks Holdings (Estados Unidos), is listed on Nasdaq with a market value of $ 887,70 Milhões, having a net worth of $ 612,95 Milhões.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ 191,37 Milhões, which generated a loss in the amount of $ -319,09 Milhões.

As for its main indicators, the Company has a P/E ratio of -2,78, a P/BV ratio of 1,45 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker DNA.

Market value

US$ 887,70 Milhões

Net worth

US$ 612,95 Milhões

US$ 612.950.000,00

Assets

US$ 1,23 Billion

US$ 1.231.010.000,00

Total Number of Shares

55,00 Milhões

55.000.000

Average Daily Trading Volume

US$ 1,63 Million

US$ 1.627.947,02

Sector

Others

Industry

Others

DNA

DNA revenue and profits

DNA results

DRAG THE FRAME TO SEE MORE DATA

DNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

DNA

Ginkgo Bioworks Holdings

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of DNA

check out the fundamentals of Ginkgo Bioworks Holdings shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings

Estados Unidos

- year

-

PROFIT X PRICE DNA

DNA results

DNA cash flow

evolution of assets - DNA

DNA balance sheet

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

CRERF - Carrefour SA

SHEL - Shell PLC ADR

ELV - Elevance Health Inc

BLSH - Bullish

BBDO - Banco Bradesco S/A ADR

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

CRERF - Carrefour SA

SHEL - Shell PLC ADR

ELV - Elevance Health Inc

BLSH - Bullish

BBDO - Banco Bradesco S/A ADR

Frequently Asked Questions